| Drug General Information |
| Drug ID |
D06LNL
|
| Former ID |
DNC011943
|
| Drug Name |
Iodyl-benzene
|
| Drug Type |
Small molecular drug
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C6H5IO2
|
| Canonical SMILES |
C1=CC=C(C=C1)I(=O)=O
|
| InChI |
1S/C6H5IO2/c8-7(9)6-4-2-1-3-5-6/h1-5H
|
| InChIKey |
BDOLQESNFGCNSC-UHFFFAOYSA-N
|
| PubChem Compound ID |
|
| Target and Pathway |
| Target(s) |
mRNA of Protein tyrosine phosphatase-1B |
Target Info |
Inhibitor |
[1]
|
|---|
|
KEGG Pathway
|
Adherens junction
|
|
Insulin signaling pathway
|
|
NetPath Pathway
|
FSH Signaling Pathway
|
|
PANTHER Pathway
|
Cadherin signaling pathway
|
|
Pathway Interaction Database
|
Insulin Pathway
|
|
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)
|
|
Signaling events mediated by PTP1B
|
|
Calcineurin-regulated NFAT-dependent transcription in lymphocytes
|
|
Signaling events mediated by TCPTP
|
|
IGF1 pathway
|
|
EGF receptor (ErbB1) signaling pathway
|
|
Posttranslational regulation of adherens junction stability and dissassembly
|
|
PDGFR-beta signaling pathway
|
|
N-cadherin signaling events
|
|
Reactome
|
Integrin alphaIIb beta3 signaling
|
|
Regulation of IFNG signaling
|
|
Regulation of IFNA signaling
|
|
Growth hormone receptor signaling
|
|
WikiPathways
|
Insulin Signaling
|
|
Growth hormone receptor signaling
|
|
Leptin signaling pathway
|
|
Interferon gamma signaling
|
|
Interferon alpha/beta signaling
|
|
Integrin alphaIIb beta3 signaling
|
| References |
| REF 1 | Bioorg Med Chem Lett. 1999 Feb 8;9(3):353-6.Periodinates: a new class of protein tyrosine phosphatase inhibitors. |
|---|
